je.st
news
Tag: phase
Genocea Commences Phase 2 Dose Optimization Trial For GEN-003 HSV-2 Immunotherapy
2014-07-30 09:52:30| drugdiscoveryonline Home Page
Genocea Biosciences, Inc. a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, recently announced the start of a Phase 2 dose optimization trial for GEN-003, the Company’s immunotherapy candidate against herpes simplex-type 2 (HSV-2)
Tags: trial
phase
dose
optimization
Medivir Ab: Phase II Cosmos Study Results Published In Lancet On World Hepatitis Day
2014-07-28 19:39:48| Appliances - Topix.net
The phase II COSMOS study evaluated the interferon-free combination of simeprevir and sofosbuvir in treatment-naive and prior null-responder patients with all stages of liver fibrosis, including cirrhosis.
FEI Adds Phase Plate Technology and Titan Halo TEM to Its Structural Biology Product Portfolio
2014-07-28 06:00:00| Industrial Newsroom - All News for Today
New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes.<br /> <br /> Hillsboro, Ore. — FEI (NASDAQ: FEIC) announced two new products for cryo-electron microscopy applications: a new phase plate solution and the Titan Halo™ transmission electron microscope (TEM). The phase plate is a stable, durable solution to increase the contrast of sensitive biological samples and is available on most TEM platforms ...This story is related to the following:Electron Microscopes
Tags: product
technology
phase
portfolio
US DoT opens Phase I of Dulles Corridor Metrorail Project
2014-07-28 01:00:00| Railway Technology
The US Department of Transportation (DoT) has opened Phase I of the $3.14bn Dulles Corridor Metrorail Project, which is also known as Silver Line.
Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients
2014-07-25 12:09:31| Chemicals - Topix.net
Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary , today announced that an investigational Phase 3 trial of NEXAVAR tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival .
Tags: meet
primary
trial
phase
Sites : [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] next »